Invention Grant
- Patent Title: Coronaviruses epitope-based vaccines
-
Application No.: US15760878Application Date: 2016-09-15
-
Publication No.: US10676511B2Publication Date: 2020-06-09
- Inventor: Jonathan Gershoni , Natalia T. Freund
- Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.
- Applicant Address: IL Tel Aviv
- Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
- Current Assignee: RAMOT AT TEL-AVIV UNIVERSITY LTD.
- Current Assignee Address: IL Tel Aviv
- Agency: Vorys, Sater, Seymour and Pease LLP
- Agent Anthony Venturino
- International Application: PCT/IL2016/051029 WO 20160915
- International Announcement: WO2017/046801 WO 20170323
- Main IPC: C07K14/005
- IPC: C07K14/005 ; A61K39/215 ; A61K39/12 ; A61P31/14
Abstract:
Provided are polypeptides derived from the coronaviruses (CoVs) Spike protein (S) characterized by high affinity and specificity the S receptor and its neutralizing antibodies. Further provided are compositions and vaccines, and vaccine-based therapies targeting CoVs, and SARS and MERS viruses in particular.
Public/Granted literature
- US20180334480A1 CORONAVIRUSES EPITOPE-BASED VACCINES Public/Granted day:2018-11-22
Information query
